Obalon Therapeutics, Inc. Urges Stockholders to IMMEDIATELY Vote FOR All Proposals Related to the Merger with ReShape Lifesciences Inc
SAN DIEGO, CA / ACCESSWIRE / May 12, 2021 / Obalon Therapeutics, Inc. (NASDAQ:OBLN) is urging its stockholders to IMMEDIATELY vote FOR the proposals put forth in its proxy statement to be voted on at the May 13, 2021 special meeting of stockholders, all of which relate to the proposed merger with ReShape Lifesciences Inc., a global weight-loss solutions company offering […]